longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ESSEX BIO-TECH

01061

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Essex Bio-Technology files HKEX next-day return disclosing share buyback at HKD 2.06

    PUBT·Sep 11 at 09:05 AM
    01061-0.73%
  • Essex Bio-Tech files HKEX next-day disclosure return on share buyback at HKD 2.07

    PUBT·Sep 10 at 08:43 AM
    01061-0.73%
  • The Unbundling of Hong Kong's Peripheral Market: Structural Realities in the Long Tail

    Global Report·Sep 8 at 11:33 AM
    01613+0.57%085210.00%
  • The Unbundling of Legacy Nodes: A Strategic View on 10 Hong Kong Equities

    Global Report·Sep 8 at 10:19 AM
    02701-1.67%02202-0.89%
  • Global Capital Rotates Into Hong Kong’s Advanced Manufacturing as Legacy Sectors Fracture

    Global Report·Sep 1 at 10:12 AM
    09630-0.58%01989-4.89%
  • Essex Bio-Tech files HKEX next-day disclosure after share buyback at HKD 2.17

    PUBT·Sep 1 at 09:10 AM
    01061-0.73%
  • Essex Bio-Tech files HKEX next-day return disclosing share repurchase at HKD 2.28-2.25

    PUBT·Aug 24 at 09:02 AM
    01061-0.73%
  • Essex Bio-Tech files HKEX next-day return disclosing share buyback at HKD 2.3

    PUBT·Aug 21 at 09:47 AM
    01061-0.73%
  • Essex Bio-Tech files HKEX next-day return on share buyback at HKD 2.3

    PUBT·Aug 19 at 08:48 AM
    01061-0.73%
  • Grand Pharma's FDA Nod and Sihuan's Aesthetics Pivot Highlight HK Market Shifts

    Global Report·Aug 11 at 10:13 AM
    02695-0.87%03288+0.07%
  • Essex Bio-Tech files HKEX next-day return disclosing share repurchase at HKD 2.37

    PUBT·Aug 7 at 08:52 AM
    01061-0.73%
  • Essex Bio-Technology Reports Profit Decline but Strong Balance Sheet in First-Half 2026

    Tip Ranks·Aug 5 at 11:39 AM
    01061-0.73%
  • Essex Bio-Technology Declares Interim Dividend for First Half of 2026

    Tip Ranks·Aug 5 at 11:39 AM
    01061-0.73%
  • Essex Bio-Technology FY26 H1 profit drops 32.2% to HK$ 110.72 million; revenue falls 10.5% to HK$ 784.69 million

    PUBT·Aug 5 at 11:24 AM
    01061-0.73%
  • Essex Bio-Tech schedules board meeting to review interim results, consider dividend

    PUBT·Jul 24 at 09:00 AM
    01061-0.73%